Stay updated on Galegenimab in Geographic Atrophy AMD: Clinical Trial
Sign up to get notified when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.

Latest updates to the Galegenimab in Geographic Atrophy AMD: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a new iteration of the page/template. This change seems to be a metadata update rather than a substantive modification to content.SummaryDifference0.0%

- Check17 days agoChange DetectedPublications section added to the study page, including a citation for Cohen Y, Usdin M, McLeod M, Kikuchi Y, Zhang M, Yang Q, Mesquida M. Deep Learning-Based Quantification of Vitreous Hyperreflective Foci as a Biomarker for Intraocular Inflammation. Ophthalmol Sci. 2026 May 28;6(8):101263. doi: 10.1016/j.xops.2026.101263. eCollection 2026 Aug., and a note that publications are automatically filled from PubMed.SummaryDifference0.2%

- Check24 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4. This reflects a small update to the site's rendering system.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a software version update. No study information or content on the page appears to be altered.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page now shows an updated Revision tag: v3.6.2, replacing v3.6.0, indicating a software update to the site’s interface.SummaryDifference0.0%

- Check60 days agoChange DetectedNo changes were detected on the page; the study details remain as published.SummaryDifference0.0%

Stay in the know with updates to Galegenimab in Geographic Atrophy AMD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.